Can Sumatriptan Be Used for Headaches Other Than Migraine?
No, sumatriptan should not be routinely used for headaches other than migraine, with the limited exception of cluster headache where subcutaneous or intranasal formulations may be considered.
FDA-Approved Indications
The FDA label is explicit and restrictive 1:
- Approved only for: Acute treatment of migraine with or without aura in adults
- Not approved for: Prevention of migraine attacks
- Specifically states: "Safety and effectiveness of sumatriptan tablets have not been established for cluster headache"
- Critical requirement: "Use only if a clear diagnosis of migraine headache has been established"
The FDA emphasizes that if a patient has no response to the first migraine attack treated with sumatriptan, you must reconsider the diagnosis before using it again 1.
Evidence-Based Exceptions
Cluster Headache (Limited Support)
The 2024 VA/DoD guidelines provide a weak recommendation for subcutaneous sumatriptan 6 mg or intranasal zolmitriptan 10 mg for acute cluster headache treatment 2. Research supports this: subcutaneous sumatriptan 6 mg achieved complete or almost complete relief in 74% of cluster headache attacks within 15 minutes, compared to 26% with placebo 3.
Key distinction: This applies only to:
- Subcutaneous 6 mg formulation (not oral)
- Intranasal formulations of triptans
- Acute cluster attacks specifically
Tension-Type Headache (Not Recommended)
For tension-type headache, guidelines recommend ibuprofen 400 mg or acetaminophen 1000 mg 2. While one ED study found no statistical difference in sumatriptan's effectiveness between migraine, probable migraine, and tension-type headaches (67% response in tension headaches) 4, this contradicts FDA labeling and established guidelines. Do not use sumatriptan for tension-type headaches - simpler, safer, and cheaper options (NSAIDs, acetaminophen) are guideline-recommended.
Clinical Algorithm for Headache Treatment
Step 1: Establish accurate diagnosis
- Migraine diagnosis confirmed → Sumatriptan appropriate (any formulation)
- Cluster headache confirmed → Consider subcutaneous sumatriptan 6 mg or intranasal triptan
- Tension-type headache → Use ibuprofen 400 mg or acetaminophen 1000 mg
- Uncertain diagnosis → Do NOT use sumatriptan; complete diagnostic workup first
Step 2: If considering sumatriptan for non-migraine headache
- Only cluster headache has any evidence support
- Use subcutaneous 6 mg (not oral formulations)
- Recognize this is off-label use for oral formulations
Critical Safety Considerations
The FDA label warns that sumatriptan can cause serious cardiovascular events including myocardial infarction, coronary artery vasospasm, arrhythmias, and stroke 1. Using it for non-migraine headaches:
- Exposes patients to unnecessary cardiovascular risk
- May delay appropriate diagnosis of serious conditions
- Risks medication overuse headache (threshold ≥10 days/month for triptans) [@2,3,4,5@]
Common pitfall: Treating "undifferentiated headaches" with sumatriptan in the ED. While one study suggested this might work 4, it violates FDA labeling, exposes patients to unnecessary risks, and may mask serious pathology. The FDA explicitly states to exclude other neurological conditions before treating 1.
Bottom Line
Sumatriptan is indicated exclusively for migraine headache. The only reasonable exception is subcutaneous sumatriptan for acute cluster headache attacks, which has weak guideline support 2 and research evidence 3. For all other headache types, use appropriate first-line treatments: NSAIDs or acetaminophen for tension-type headaches, and specific therapies for secondary headaches once identified. Using sumatriptan for "undifferentiated" or non-migraine headaches is not supported by FDA labeling 1, exposes patients to cardiovascular risks 1, and represents poor clinical practice.